The Vitex Wonderland facility in Western Sydney has officially opened, marking a A$250 million bet on Australian medicine making by one of the country’s largest contract manufacturers. Vitex Pharmaceuticals Pty Ltd, the Chami family business established in 1989, inaugurated the Eastern Creek plant in early July 2026 at a ceremony attended by Prime Minister Anthony Albanese and New South Wales Premier Chris Minns, alongside executive chairman Dr Elie Chami and chief executive Dr Aniss Chami. Industry outlet BioPharma APAC reports the project as the country’s largest investment in pharmaceutical manufacturing, while trade publication Pharmacy Daily describes it as the most significant such investment in more than two decades.

Wonderland sits adjacent to the company’s original 2017 plant at Eastern Creek, a A$100 million facility that was itself opened by a sitting prime minister, Malcolm Turnbull, and built capacity for roughly 20 billion tablets and capsules a year. The new development triples the Vitex production footprint and extends its manufacturing licence beyond complementary medicines into registered medicines, including Schedule 4 prescription products. That regulatory step matters. According to Dr Aniss Chami, 61 percent of medicines supplied in Australia in 2023 were imported and more than 400 medicines were in shortage by mid 2024, so a domestic plant licensed for prescription manufacturing directly addresses gaps in sovereign supply. Once fully operational, Wonderland is expected to rank among the largest pharmaceutical manufacturing facilities in the Southern Hemisphere, and the company projects 800 new roles across engineering, research and development, operations and quality assurance.

Western Sydney Joins a National Wave of Food and Pharma Manufacturing Investment

The Vitex Wonderland cost of A$250 million lands within a broader Australian push to reshore advanced manufacturing, and Western Sydney is capturing an outsized share of it. Eastern Creek has matured into one of the country’s premier industrial precincts, anchored by estates such as the Eastern Creek Business Park developed by Frasers Property Industrial, whose listing records Vitex as occupier of a 34,439 square metre facility at 2 Wonderland Drive comprising 24,189 square metres of warehousing, a 4,858 square metre office and 352 parking spaces. Vitex has also signed with the NSW Government for a pharmaceutical training and research institute at the Western Sydney Aerotropolis, an initial A$10 million commitment designed to train up to 200 students at a time and feed skilled workers into the sector. The pattern of manufacturers doubling down on Australian soil extends well beyond pharma. In South Australia, Haigh’s Chocolates committed A$130 million to a new Salisbury South plant to double its chocolate production capacity, a project Construction Review Online covered at announcement in December 2023. That facility, built by CIP Constructions to a BELL Architects design, opened on 16 September 2025 at a reported final cost of A$120 million and lifts annual output from 1,100 to 2,000 tonnes. Together the two projects show family owned Australian manufacturers scaling up onshore rather than offshoring production.

Vitex Wonderland Timeline and What Comes Next

The latest news is the official opening, but the Vitex Wonderland timeline still has distance to run before the site hits full capacity. Reports from Pharmacy Daily frame Southern Hemisphere leadership as a milestone the plant reaches once fully operational, which implies a staged ramp of production lines, client onboarding and recruitment toward the 800 promised roles rather than an immediate switch to full output. Open questions remain around how quickly Schedule 4 prescription volumes materialise, since contract manufacturing programmes for registered medicines carry longer qualification and regulatory lead times than the vitamins and supplements on which Vitex built its name. The company has previously flagged international ambitions, with earlier reporting pointing to planned facilities offshore, so Wonderland’s performance will likely shape how far and how fast that expansion proceeds. For Western Sydney, the payoff is concrete: hundreds of skilled manufacturing jobs, a deeper pharmaceutical ecosystem around the Aerotropolis, and strengthened domestic supply of medicines at a time when shortages remain a live policy concern.

Project Fact Sheet

• Project Name: Wonderland, Vitex Pharmaceuticals manufacturing facility
• Location: Eastern Creek, Western Sydney, New South Wales, Australia
• Project Value: A$250 million, per Vitex and industry reports
• Client/Owner: Vitex Pharmaceuticals Pty Ltd
• Main Contractor: Not publicly disclosed
• Facility Size: 34,439 square metres, per the Frasers Property Industrial listing for 2 Wonderland Drive
• Key Components: Manufacturing suites spanning Schedule 2 medicines sold over the counter through Schedule 4 prescription medicines, warehousing of 24,189 square metres, a 4,858 square metre office and quality assurance functions
• Officially Opened: Early July 2026, by Prime Minister Anthony Albanese and NSW Premier Chris Minns
• Jobs Created: 800 new roles across engineering, research and development, operations and quality assurance
• Regulatory Scope: Manufacturing licence extended to registered medicines, including Schedule 4 prescription products
• Strategic Impact: Strengthens Australian sovereign medicine supply; expected to rank among the largest pharmaceutical manufacturing facilities in the Southern Hemisphere once fully operational

Project Team

• Client/Owner: Vitex Pharmaceuticals Pty Ltd
• Executive Chairman: Dr Elie Chami
• Chief Executive Officer: Dr Aniss Chami
• Main Contractor: Not publicly disclosed
• Estate Developer (Eastern Creek Business Park): Frasers Property Industrial
• Government Partners at Opening: Australian Government (Prime Minister Anthony Albanese) and NSW Government (Premier Chris Minns)

Frequently Asked Questions

How much did the Vitex Wonderland facility cost? The Vitex Wonderland facility cost A$250 million, the largest investment in Australian pharmaceutical manufacturing in more than two decades according to industry reports.

Where is the Vitex Wonderland facility located? The facility is located at Eastern Creek in Western Sydney, New South Wales, adjacent to the original Vitex plant that opened in 2017.

How many jobs will the Vitex Wonderland facility create? Vitex expects 800 new roles across engineering, research and development, operations and quality assurance as the plant ramps up.

What will the Vitex Wonderland facility manufacture? Wonderland is licensed to manufacture the full spectrum of medicines under one roof, from Schedule 2 products sold over the counter through Schedule 4 prescription medicines.

Who opened the Vitex Wonderland facility? Prime Minister Anthony Albanese and NSW Premier Chris Minns officially opened the facility in early July 2026 alongside Vitex executive chairman Dr Elie Chami and CEO Dr Aniss Chami.